Literature DB >> 16365122

Who is the ideal candidate for autologous chondrocyte implantation?

S P Krishnan1, J A Skinner, W Bartlett, R W J Carrington, A M Flanagan, T W R Briggs, G Bentley.   

Abstract

We investigated the prognostic indicators for collagen-covered autologous chondrocyte implantation (ACI-C) performed for symptomatic osteochondral defects of the knee. We analysed prospectively 199 patients for up to four years after surgery using the modified Cincinnati score. Arthroscopic assessment and biopsy of the neocartilage was also performed whenever possible. The favourable factors for ACI-C include younger patients with higher pre-operative modified Cincinnati scores, a less than two-year history of symptoms, a single defect, a defect on the trochlea or lateral femoral condyle and patients with fewer than two previous procedures on the index knee. Revision ACI-C in patients with previous ACI and mosaicplasties which had failed produced significantly inferior clinical results. Gender (p = 0.20) and the size of the defect (p = 0.97) did not significantly influence the outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16365122     DOI: 10.1302/0301-620X.88B1.16796

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  51 in total

1.  Sequential outcome following autologous chondrocyte implantation of the knee: a six-year follow-up.

Authors:  Benedict A Rogers; Lee A David; Tim W R Briggs
Journal:  Int Orthop       Date:  2009-08-11       Impact factor: 3.075

2.  The role of rehabilitation following autologous chondrocyte implantation: a retrospective chart review.

Authors:  Jenny L Toonstra; Jennifer S Howard; Timothy L Uhl; Robert A English; Carl G Mattacola
Journal:  Int J Sports Phys Ther       Date:  2013-10

Review 3.  Cartilage lesions in patellofemoral dislocations: incidents/locations/when to treat.

Authors:  Jack Farr; D Jeff Covell; Christian Lattermann
Journal:  Sports Med Arthrosc Rev       Date:  2012-09       Impact factor: 1.985

4.  Current treatments of isolated articular cartilage lesions of the knee achieve similar outcomes.

Authors:  Hong-Chul Lim; Ji-Hoon Bae; Sang-Heon Song; Young-Eun Park; Seung-Ju Kim
Journal:  Clin Orthop Relat Res       Date:  2012-03-16       Impact factor: 4.176

5.  Implantation of matrix-induced autologous chondrocyte (MACI ®) grafts using carbon dioxide insufflation arthroscopy.

Authors:  Alberto Vascellari; Enrico Rebuzzi; Stefano Schiavetti; Nicolò Coletti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-16       Impact factor: 4.342

6.  The role of autologous chondrocyte implantation in the treatment of symptomatic chondromalacia patellae.

Authors:  Simon Macmull; Parag K Jaiswal; George Bentley; John A Skinner; Richard W J Carrington; Tim W R Briggs
Journal:  Int Orthop       Date:  2012-01-14       Impact factor: 3.075

7.  Validation of the Oswestry Risk of Knee Arthroplasty Index (ORKA-1) for Patients Undergoing Autologous Chondrocyte Implantation.

Authors:  Jakob Ackermann; Alexandre Barbieri Mestriner; Dillon Arango; Takahiro Ogura; Andreas H Gomoll
Journal:  Cartilage       Date:  2018-08-27       Impact factor: 4.634

8.  Autologous chondrocyte implantation to repair knee cartilage injury: ultrastructural evaluation at 2 years and long-term follow-up including muscle strength measurements.

Authors:  Sverre Løken; Tom C Ludvigsen; Turid Høysveen; Inger Holm; Lars Engebretsen; Finn P Reinholt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-07-02       Impact factor: 4.342

Review 9.  Early osteoarthritis of the patellofemoral joint.

Authors:  Elizabeth A Arendt; Massimo Berruto; Giuseppe Filardo; Mario Ronga; Stefano Zaffagnini; Jack Farr; Paolo Ferrua; Alberto Grassi; Vincenzo Condello
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

Review 10.  Cartilage repair techniques of the talus: An update.

Authors:  Mike H Baums; Wolfgang Schultz; Tanja Kostuj; Hans-Michael Klinger
Journal:  World J Orthop       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.